Source: Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options



Rating:

Share or cite this content

Citations should be made in the following way:
P. Spagnolo (Padova (PD), Italy). Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities. Virtual Congress 2021 – Interstitial lung diseases: from disease mechanisms to novel treatment options

Member's Comments

No comment yet.

Related content which might interest you: Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Source: Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019 Year: 2019 Progress in the pathology of diffuse lung disease in infancy: changing concepts and diagnostic challenges Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=21 Year: 2007 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Interstitial lung disease: new challenges and evolving phenotypes Source: Eur Respir Rev 2009; 19: 91-93 Year: 2010 Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Current challenges in diagnosing and treating adults with interstitial lung disease Source: International Congress 2014 – PG01 Challenges faced when diagnosing idiopathic interstitial lung disease Year: 2014 Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Diffuse parenchymal lung disease: a practical overview Is a lung biopsy necessary for management? Source: Breathe 2008; 4: 233-239 Year: 2008 Current and future therapeutic approaches in idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: 693-703 Year: 2005 Clinical pitfalls in diagnosing interstitial lung disease Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 Teleradiology in interstitial lung disease: first experiences Source: International Congress 2017 – Rare diseases Year: 2017 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists? Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 ¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Monitoring early lung disease in cystic fibrosis: where are we now? Source: Breathe 2014; 10: 34-47 Year: 2014 Opportunities of SPECT-CT in the diagnosis of vascular complications of interstitial lung diseases Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010